CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

We recently published a list of Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks. In this article, we are going ...

With a market cap of $80.4 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company headquartered in ...

Ratings for CVS Health CVS were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish ...

Elevance Health reported a benefit expense ratio of 86.4% in the first quarter, up 80 bps year over year, mainly because Medicaid rates failed to keep up with medical cost trends. High-cost trends ...

CVS HealthCVS and The Cigna GroupCI stand as two dominant forces in the U.S. diversified healthcare sector, commanding market capitalizations of approximately $77 billion and $84 billion, respectively ...

CVS Health's stock price increase comes after a period ... landing at $2.4 billion compared to $3.4 billion in the prior year. Examining performance at the segment level can help us better ...

Price to Sales (P/S) Ratio: The P/S ratio of 0.21 is lower than the industry average, implying a discounted valuation for CVS Health's stock in relation to sales performance. EV/EBITDA Analysis ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.